Pages that link to "Q35954892"

The following pages link to Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation (Q35954892):

Displaying 48 items.

• Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells (Q28547140) (← links)
• Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer (Q28547364) (← links)
• Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma (Q28816972) (← links)
• Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer (Q34042731) (← links)
• In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma (Q34476559) (← links)
• AMPK-activated protein kinase activation by Impatiens balsamina L. is related to apoptosis in HSC-2 human oral cancer cells (Q35086813) (← links)
• Safety and otoprotection of metformin in radiation-induced sensorineural hearing loss in the guinea pig. (Q35087146) (← links)
• Reduction behavior induced by HL010183, a metformin derivative against the growth of cutaneous squamous cell carcinoma (Q35145204) (← links)
• Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3. (Q35164428) (← links)
• Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle (Q35582737) (← links)
• Cytotoxic effect of Erythroxylum daphnites extract is associated with G1 cell cycle arrest and apoptosis in oral squamous cell carcinoma (Q35936878) (← links)
• Anti-tumor effects of metformin on head and neck carcinoma cell lines: A systematic review (Q36327585) (← links)
• Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies (Q36370966) (← links)
• Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis (Q36557279) (← links)
• Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. (Q36604614) (← links)
• Metformin - For the dermatologist (Q36651435) (← links)
• Metformin may reduce oral cancer risk in patients with type 2 diabetes (Q36739022) (← links)
• The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study (Q37193603) (← links)
• Metformin targets c-MYC oncogene to prevent prostate cancer. (Q37354564) (← links)
• The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug (Q37501673) (← links)
• Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress (Q37649672) (← links)
• New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells (Q38187997) (← links)
• Proteomic modulation in breast tumors after metformin exposure: results from a "window of opportunity" trial. (Q38391252) (← links)
• Metformin and the risk of head and neck cancer: a case-control analysis (Q38419680) (← links)
• Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review. (Q39305660) (← links)
• Diabetes mellitus as a prognostic marker in oropharyngeal and laryngeal squamous cell carcinoma (Q40699186) (← links)
• The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS). (Q41233466) (← links)
• Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells. (Q42272463) (← links)
• Head and neck cancers, the neglected malignancies: present and future treatment strategies (Q44655644) (← links)
• Effect of metformin on the incidence of head and neck cancer in diabetics. (Q46006826) (← links)
• Genotoxic investigation of a thiazolidinedione PPARγ agonist using the in vitro micronucleus test and the in vivo homozygotization assay (Q46603087) (← links)
• Down-regulation of malic enzyme 1 and 2: Sensitizing head and neck squamous cell carcinoma cells to therapy-induced senescence (Q46726131) (← links)
• New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways (Q47246957) (← links)
• Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial (Q48254107) (← links)
• Therapeutic potential of the anti-diabetic agent metformin in targeting the skin cancer stem cell diaspora. (Q52647753) (← links)
• Anti-proliferative Effect of 15,16-Dihydrotanshinone I Through Cell Cycle Arrest and the Regulation of AMP-activated Protein Kinase/Akt/mTOR and Mitogen-activated Protein Kinase Signaling Pathway in Human Hepatocellular Carcinoma Cells. (Q55544709) (← links)
• Metformin Results in Diametrically Opposed Effects by Targeting Non-Stem Cancer Cells but Protecting Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma (Q60919666) (← links)
• Targeting cellular metabolism to reduce head and neck cancer growth (Q64067820) (← links)
• Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity (Q64098059) (← links)
• Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. (Q64911676) (← links)
• Improvement of chronic Peyronie's disease symptoms after diabetic compensation: a retrospective study (Q86190460) (← links)
• Association of Diabetes with Oral Cancer- an Enigmatic Correlation (Q90655014) (← links)
• MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis (Q91199171) (← links)
• Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study (Q92180690) (← links)
• Betulin Inhibits Lung Metastasis by Inducing Cell Cycle Arrest, Autophagy, and Apoptosis of Metastatic Colorectal Cancer Cells (Q92326257) (← links)
• Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines (Q93059348) (← links)
• ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer (Q98289643) (← links)
• A CRISPR knockout negative screen reveals synergy between CDKs inhibitor and metformin in the treatment of human cancer in vitro and in vivo (Q98564727) (← links)